NONMEM Users Network Archive

Hosted by Cognigen

Career Opportunity at Moderna: Senior Scientist, Pharmacometrics

From: Husain Attarwala <Husain.Attarwala>
Date: Mon, 1 Jun 2020 15:30:01 +0000

Dear NMusers,

An exciting opportunity to contribute towards developing mRNA therapeutics =
and vaccines. The clinical pharmacology and pharmacometric group at Moderna=
 therapeutics is seeking a talented pharmacometrician to join our team. Ple=
ase follow the link below for the job description and online application.

Sr. Scientist Pharmacometrics<


Husain Attarwala, PhD
Head of Pharmacometrics | Moderna |<>
 [signature_2127785708] <>
[signature_1146048737]<> [signature_11817=
6511] <> [signature_1781966198] <http://=> [signature_1489564253] <https://linkedin.c=

P Please consider the environment before printing this email

Confidentiality notice and disclaimer: The information in this message and =
any attachments is intended for the exclusive use of the addressee(s), is c=
onfidential and may be privileged or otherwise protected from disclosure. A=
ny review, retransmission, dissemination or other use of, or taking of any =
action in reliance upon, of any such information by persons or entities oth=
er than the intended addressee(s) is prohibited. If you have received this =
message in error and are not the intended addressee, please notify the send=
er immediately and delete this message and any attachments from your system=
 without reading or disclosing them. If you are not the intended addressee,=
 be advised that any use of the information in this message and any attachm=
ent is prohibited and may be unlawful, and you must not copy this message o=
r attachment or disclose the contents to any other person.

(image/jpeg attachment: image011.jpg)

(image/jpeg attachment: image012.jpg)

(image/jpeg attachment: image013.jpg)

(image/jpeg attachment: image014.jpg)

(image/jpeg attachment: image015.jpg)

Received on Mon Jun 01 2020 - 11:30:01 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to:

Once subscribed, you may contribute to the discussion by emailing: